Skokie, IL 2/8/17—Integrated DNA Technologies (IDT), a provider of custom nucleic acid products for life sciences, has acquired GeneWorks’ oligonucleotide manufacturing business for an undisclosed amount. GeneWorks is based in Australia. “With this acquisition, we are furthering our goal of making our world class products and services more easily accessible to scientists around the world. We look forward to availing GeneWorks’ customers of our unrivaled manufacturing capabilities, design expertise and fast turnaround times,” commented IDT Founder and CEO Dr. Joseph A. Walder.

Geneworks’ oligonucleotide manufacturing is based in Australia. This is IDT’s third Asia Pacific–based acquisition in two years (see IBO 12/1/15, 6/15/16), as the company continues to build a foothold in the region, targeting oligonucleotide manufacturing capacity and distribution.